HK1016590A1 - Pharmaceutical compositions comprising famciclovir monohydrate - Google Patents

Pharmaceutical compositions comprising famciclovir monohydrate

Info

Publication number
HK1016590A1
HK1016590A1 HK99101518A HK99101518A HK1016590A1 HK 1016590 A1 HK1016590 A1 HK 1016590A1 HK 99101518 A HK99101518 A HK 99101518A HK 99101518 A HK99101518 A HK 99101518A HK 1016590 A1 HK1016590 A1 HK 1016590A1
Authority
HK
Hong Kong
Prior art keywords
pharmaceutical compositions
famciclovir monohydrate
famciclovir
monohydrate
pharmaceutical
Prior art date
Application number
HK99101518A
Other languages
English (en)
Inventor
Kenneth Churchill Campbell
Michael John Greenway
Stephen Andrew Hancock
Original Assignee
Novartis Int Pharm Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9602403.9A external-priority patent/GB9602403D0/en
Priority claimed from GBGB9618494.0A external-priority patent/GB9618494D0/en
Application filed by Novartis Int Pharm Ltd filed Critical Novartis Int Pharm Ltd
Publication of HK1016590A1 publication Critical patent/HK1016590A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HK99101518A 1996-02-07 1999-04-12 Pharmaceutical compositions comprising famciclovir monohydrate HK1016590A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9602403.9A GB9602403D0 (en) 1996-02-07 1996-02-07 Pharmaceuticals
GBGB9618494.0A GB9618494D0 (en) 1996-09-05 1996-09-05 Pharmaceuticals
PCT/EP1997/000523 WO1997029108A1 (en) 1996-02-07 1997-02-04 Famciclovir monohydrate

Publications (1)

Publication Number Publication Date
HK1016590A1 true HK1016590A1 (en) 1999-11-05

Family

ID=26308618

Family Applications (1)

Application Number Title Priority Date Filing Date
HK99101518A HK1016590A1 (en) 1996-02-07 1999-04-12 Pharmaceutical compositions comprising famciclovir monohydrate

Country Status (8)

Country Link
EP (1) EP0885223B1 (xx)
JP (1) JP4183750B2 (xx)
AR (1) AR005730A1 (xx)
AU (1) AU1601397A (xx)
DE (1) DE69706833T2 (xx)
ES (1) ES2165020T3 (xx)
HK (1) HK1016590A1 (xx)
WO (1) WO1997029108A1 (xx)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100369913C (zh) * 2002-08-26 2008-02-20 特瓦制药工业有限公司 Ⅰ晶型、ⅱ晶型、ⅲ晶型泛昔洛韦及其制备方法
AU2003268213A1 (en) * 2002-08-26 2004-03-11 Teva Pharmaceutical Industries Ltd. Crystalline solid famciclovir forms i, ii, iii and preparation thereof
JP4731121B2 (ja) * 2004-02-02 2011-07-20 協和発酵キリン株式会社 キサンチン誘導体水和物
JP2007538087A (ja) 2004-05-18 2007-12-27 テバ ファーマシューティカル インダストリーズ リミティド 結晶固形ファムシクロビルを調製するための乾燥方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0182024B1 (en) * 1984-09-20 1991-04-03 Beecham Group Plc Purine derivatives and their pharmaceutical use

Also Published As

Publication number Publication date
EP0885223B1 (en) 2001-09-19
EP0885223A1 (en) 1998-12-23
AU1601397A (en) 1997-08-28
DE69706833D1 (de) 2001-10-25
WO1997029108A1 (en) 1997-08-14
JP2000504679A (ja) 2000-04-18
DE69706833T2 (de) 2002-04-11
ES2165020T3 (es) 2002-03-01
AR005730A1 (es) 1999-07-14
JP4183750B2 (ja) 2008-11-19

Similar Documents

Publication Publication Date Title
EG24118A (en) Pharmaceutical compositions
GB9727053D0 (en) Pharmaceutical compositions
CY2569B1 (en) Pharmaceutical compositions
GB9616672D0 (en) Pharmaceutical compositions
ZA9710006B (en) Novel pharmaceutical compositions
GB9610359D0 (en) Pharmaceutical compositions
IL131995A0 (en) Gastric-retained pharmaceutical compositions
GB9723985D0 (en) Pharmaceutical compositions
ZA9710919B (en) Pharmaceutical compositions containing N-sulphony-lindole derivatives
ZA979726B (en) Pharmaceutical compositions
GB9726735D0 (en) Pharmaceutical compositions
GB9606429D0 (en) Pharmaceutical compositions
GB9613457D0 (en) Pharmaceutical compositions
HU9700632D0 (en) Pharmaceutical compositions
HK1016590A1 (en) Pharmaceutical compositions comprising famciclovir monohydrate
GB9618376D0 (en) Pharmaceutical compositions
GB9610136D0 (en) Pharmaceutical compositions
HUP0003528A3 (en) Pharmaceutical compositions containing dihydropolyprenols
ZA982117B (en) Pharmaceutical compositions
GB9603942D0 (en) Pharmaceutical compositions
GB9606586D0 (en) Pharmaceutical compositions
GB9603141D0 (en) Pharmaceutical formulation
GB9725563D0 (en) Pharmaceutical compositions
GB9710505D0 (en) Pharmaceutical compositions
GB9722066D0 (en) Pharmaceutical compositions

Legal Events

Date Code Title Description
CORR Corrigendum

Free format text: CORRECTED DATA OF SECTION 27 TO JOURNAL OF : [54] PHARMACEUTICAL COMPOSITIONS COMPRISING FAMCICLOVIR - MONOHYDRATE

Free format text: CORRECTED DATA OF SECTION 27 TO JOURNAL OF : [54] ENDOTHELIN RECEPTOR ANTAGONISTS

PF Patent in force
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20110204